• AAPL 165.75
  • TSLA 149.81
  • AMZN 177.195
  • MSFT 403.655
  • INTC 34.77
  • EURUSD 1.0668
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. PLUR.NASDAQ

Pluri Inc. (PLUR NASDAQ) stock market data APIs

$5.08 0.03(0.6%) as of April 18, 2024

Pluri Inc. Financial Data Overview

5.05
5.08
-
5.185
5
3.44-8.56
26 397 K
5 227 K
357 K
-0.1181
1.511
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PLUR',
Type: 'Common Stock',
Name: 'Pluri Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: NULL,
CUSIP: NULL,
CIK: '1158780',
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: '2003-06-30',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Pluri Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 357 K
  • EBITDA -23 938 000
  • Earnings Per Share -4.64
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Pluri Inc. Earnings via APIs

  • Latest Release 2024-02-12
  • EPS/Forecast -0.32

Get Pluri Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Pluri Inc. latest news via APIs

Pluri’s PLX-R18 Increases Blood Cell Counts and Reduces Need for Transfusions in a Phase I Study: Results Published in Nature Bone Marrow Transplantation

Results support the development of PLX-R18 for hematologic acute radiation syndrome (H-ARS), currently under a $4.2 million contract with the U.S. National Institutes of Health PLX-R18 has the advanta...
  • CELL THERAPY
  • HEMATOLOGY
  • NASDAQ:PLUR
  • NATURE BMT
  • PLURI
  • PLURI INC
  • PRODUCT / SERVICES ANNOUNCEMENT

Pluri Announces Appointment of Entrepreneur Lorne Abony to Board of Directors

HAIFA, Israel, July 13, 2023 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promot...
  • DIRECTORS AND OFFICERS
  • NASDAQ:PLUR
  • PLURI INC
Do you have any questions?
support@eodhistoricaldata.com